Sun, 15-Mar 2026

Search news articles
  • Home
  • AllAgricultureBankingAviationEnergyManufacturingTechnologyStartups
  • Geopolitics
  • Kenya Business NewsAfrican Business NewsGlobal News
  • Press Releases
  • Shows
  • Best Places to Work 2026
Subscribe
Events
Subscribe
  • Home
  • AllAgricultureBankingAviationEnergyManufacturingTechnologyStartups
  • Geopolitics

    Contact Us

    Media Queries & Partnerships:[email protected]

    About Us

    We are a leading integrated digital content platform providing in-depth business and financial news across Sub-Saharan Africa & the globe.

    Disclaimer

    The information contained in this website is for general information purposes only.
    © 2026 Wallstreet Africa Technologies LTD.. All Rights Reserved.
    1.0.32

    In cooperation with WHO, the AVA Pharmaceuticals (Pvt) Ltd company starts delivering generic drugs for hepatitis B and C, HIV treatment to South American countries

    Business
    By Business Reporter
    - July 16, 2019
    - July 16, 2019
    Sponsored Posts

    Under the patronage of WHO, the AVA Pharmaceuticals (Pvt) Ltd company starts delivering generics to South American countries within the framework of the humanitarian mission. The issue is five drugs used to treat hepatitis B virus and hepatitis C virus, HIV infections under antiretroviral therapy.

    The AVA Pharmaceuticals (Pvt) Ltd supplies the following medications:

    1. •Sofodac (each pill of the medication contains 60 mg of daclatasvir and 400 mg of sofosbuvir). This drug is effective to treat hepatitis C virus genotypes 2a, 3a, 4a and 1b.
    2. •Sofovel (velpatasvir and sofosbuvir are active substances). All genotypes of hepatitis C can be treated with this medication.
    3. •Tafaday (tenofovir alafenamide is the active ingredient). These pills demonstrate the antiviral activity against HIV and the hepatitis B virus.
    4. •Encor (entecavir is the main active ingredient). This drug is used to treat chronic hepatitis B.
    5. •Zeprid (each pill of the medication contains 300 mg of tenofovir disoproxil fumarate). This drug is active against the hepatitis B virus and HIV.

    It is planned that the monthly supplies will be equal to about 10000 courses. All the drugs conform to international quality and safety standards and are highly effective. These deliveries will be a true salvation for millions of patients living in the countries of South America.

    The Kenyan Wall Street

    We are a leading integrated digital content platform providing in-depth business and financial news across Africa & the globeSubscribe
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...
    Loading...

    Your edge in markets, powered by AI

    Explore cutting-edge insights with our AI assistant, delivering real-time analysis, personalized news, and in-depth answers at your fingertips.

    Sign Up

    Show me today’s top trades

    Explain the market in simple terms

    What’s my next smart move?

    Report Issue

    Wall Street Africa Business Intelligence

    Access exclusive news, expert analysis, and tools designed to give investors an edge.

    Fixed Income

    Real-time bond pricing with instant calculations, auction data, yield curves, and trend analysis for Africa’s fixed-income markets.

    Local and Global Insights

    Unique perspective with a blend of local and global news and analysis, tailored for African investors.

    Real-Time Economic Indicators

    Monitor inflation, currency movements, and other key economic indicators for African countries.

    Interactive Data for Local Markets

    Visualize trends and compare markets across Africa with interactive charts and tools.
    Wallstreet Africa
    Wallstreet Africa
    Wallstreet Africa